CAPTRUST Financial Advisors
ELI

CAPTRUST Financial Advisors’s ELITE PHARMACEUTICAL ELI Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ELI Stock Details ELI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-48,778
Closed -$2K – 4957
2021
Q2 		$2K Hold
48,778
– – ﹤0.01% 4258
2021
Q1 		$3K Hold
48,778
– – ﹤0.01% 3969
2020
Q4 		$3K Hold
48,778
– – ﹤0.01% 3066
2020
Q3 		$3K Hold
48,778
– – ﹤0.01% 2712
2020
Q2 		$4K Buy
+48,778
New +$4K ﹤0.01% 2477
2019
Q4 		– Sell
-48,778
Closed -$4K – 2077
2019
Q3 		$4K Buy
+48,778
New +$4K ﹤0.01% 1718

Other funds holding ELI

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CAPTRUST Financial Advisors's ELI Position: Q3 2021 in Review

CAPTRUST Financial Advisors sold out of ELITE PHARMACEUTICAL (ELI) in Q3 2021, closing a stake of 48,778 shares — an estimated $2K sold.

CAPTRUST Financial Advisors first reported a position in ELI in Q3 2019 and held it in 6 quarters. The position peaked at $4K in Q2 2020. 1 fund tracked by Wall St. Rank holds ELI as of Q3 2021.

  • CAPTRUST Financial Advisors reported no remaining ELITE PHARMACEUTICAL position as of Q3 2021 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 48,778 ELITE PHARMACEUTICAL shares in Q3 2021, an estimated $2K.
  • CAPTRUST Financial Advisors first reported a position in ELITE PHARMACEUTICAL in Q3 2019 and held it in 6 quarters.
  • CAPTRUST Financial Advisors's ELITE PHARMACEUTICAL position peaked at $4K in Q2 2020.
  • 1 fund tracked by Wall St. Rank held ELITE PHARMACEUTICAL as of Q3 2021.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.